Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
CF Boehringer und Soehne GmbH
Original Assignee
Boehringer Mannheim GmbH
CF Boehringer und Soehne GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH, CF Boehringer und Soehne GmbHfiledCriticalBoehringer Mannheim GmbH
Publication of ES263140A1publicationCriticalpatent/ES263140A1/es
Procedimiento para la preparación de nuevos estrofantidol-glicósidos, caracterizado porque el estrofantidin-digitoxósido o bien el correspondiente digitoxósido-glucósido, se le trata con agentes de reducción capaces de transformar el grupo aldehido de la estrofantidina en un grupo alcohol primario conservando el anillo de lactona no saturado.
ES0263140A1959-12-181960-12-10Procedimiento para la preparacion de nuevos estrofantidolglicosidos
ExpiredES263140A1
(es)